Page last updated: 2024-11-02

pentobarbital and Dermatitis, Contact

pentobarbital has been researched along with Dermatitis, Contact in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Dermatitis, Contact: A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
White, K1
Bruckner, JV1
Guess, WL1

Other Studies

1 other study available for pentobarbital and Dermatitis, Contact

ArticleYear
Toxicological studies of 2-mercaptoethanol.
    Journal of pharmaceutical sciences, 1973, Volume: 62, Issue:2

    Topics: Administration, Oral; Animals; Body Weight; Central Nervous System; Dermatitis, Contact; Drug Intera

1973